USP28 and heart failure: Here, we applied a recently reported USP28-specific inhibitor OB and showed that selective inhibition of USP28 by OB abrogates TAC-induced established hypertrophic heart failure and oxidative stress, indicating OB as a potential candidate for the treatment of heart failure.